AzTrials
AzTrials

Incisional HerniaNCT04311788

Preemer Trial - Prophylactic Mesh Versus no Mesh in the Midline Emergency Laparotomy Closure for Prevention of Incisional Hernia: a Multi Center, Double-blind, Randomized Controlled Trial

A study testing Prophylactic self gripping mesh and Slowly absorbable continuous monofilament suture in people with Incisional Hernia and Emergency Laparotomy, run by University of Oulu at 7 sites in Finland.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

244 patients, who have an emergency midline laparotomy for any gastrointestinal reason, will be randomized in a 1:1 ratio either to mesh group with a retrorectus prophylactic self-gripping mesh or to control group with 4:1 small stitch closure by continuous monofilament suture. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Prophylactic self gripping mesh and Slowly absorbable continuous monofilament suture
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
109 participants
Where
7 sitesFinland
Study dates
27 Apr 2020to Mar 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Midline emergency laparotomy for any gastrointestinal indication

Who cannot join

  • • Previous ventral hernia repair with mesh in the midline
  • Previous inguinal or femoral hernia repair by any technique with mesh is accepted
  • Previous WHO class of physical activity 3-4 (WHO 3 more than 50% of time at rest, WHO 4 stays at rest most of the time)
  • Relaparotomy
  • Indication for laparotomy is incarcerated hernia
  • Pregnant or suspected pregnancy
Show all 18Show fewer
  • <18 years
  • Metastastic malignancy of any origin
  • Planned osteomyelitis
  • Patients living geographically distant and/or unwilling to return for follow-ups
  • No informed consent
  • Subject participates in another RCT Intra-operative exclusion criteria applicable for both randomization groups
  • Abdomen is left open
  • Second look laparotomy planned
  • Ostomy created at the operation
  • Inability to keep the mesh securely out of the peritoneal cavity or close the anterior fascia
  • Intra-abdominal malignancy diagnosed at the operation
  • >2 cm hernia in midline

Trial locations and contacts

7 sites in 1 country.

7 sites in 1 country

Finland7 sites
  • Jorvi Hospital

    Espoo

  • Helsinki University Hospital

    Helsinki

  • Lahti Central Hospital

    Lahti

  • Oulu University Hospital

    Oulu

  • Seinäjoki Central Hospital

    Seinäjoki

  • Tampere University Hospital

    Tampere

  • Turku University Hospital

    Turku

Other trials in Finland

About this study

244 patients, who have an emergency midline laparotomy for any gastrointestinal reason, will be randomized in a 1:1 ratio either to mesh group with a retrorectus prophylactic self-gripping mesh or to control group with 4:1 small stitch closure by continuous monofilament suture. They will be followed up at 30 days, 2 and 5 years to detect the incidence of incisional hernia.

Read the detailed description

Incisional hernia (IH) is a common complication of abdominal wall surgery. Its' incidence varies greatly (2-30 %) among studies. The incisional hernia incidence is influenced by several factors, such as closing technique, follow-up time and the modality of radiological investigations, patient characteristics and co-morbidities as well as indication and type for surgery.

European Hernia Society (EHS) guideline strongly recommends to utilise a non-midline approach to a laparotomy whenever possible to decrease the incidence of incisional hernia. However, this is clearly not an option in an emergency laparotomy, as midline incision is the fastest and the best visualizing opening to explore the whole abdominal cavity in an emergency setting.

For elective midline incisions, evidence-based recommendation is to perform a continuous suturing technique with slowly absorbable monofilament suture when closing the incision. Suturation should be done performing a single layer aponeurotic closure technique without separate closure of the peritoneum. A small bites technique with a suture to wound length (SL/WL) ratio at least 4:1 is the current recommended method of fascial closure.

Prophylactic mesh augmentation in a non-emergency setting appears effective and safe and can be suggested for high-risk patients. However, no recommendations can be given on the optimal technique to close emergency laparotomy incisions because of lack of evidence. This problem should be emphasized on due to high rates of IH after emergency laparotomy. All this makes the use of prophylactic mesh in the emergency setting an interesting proposition, as it may decrease the rate of IHs. However, there are concerns over potential mesh related complications including infection, chronic pain, seromas and bowel fistulas especially in emergency situations like peritonitis and intestinal obstruction. There is preliminary evidence published about the safety and efficiency of the prevention of IHs using meshes in the emergency laparotomy closure even in contaminated conditions.

In the resent systematic review and meta-analysis, only results of 2 studies and altogether 299 patients were eligible for the analysis. Swiss case-control study reported an IH rate of 3,2% (2/63) in the mesh group and 28,6% (20/70) in the control group. Spanish study group had the same kind of results in their retrospective cohort; IH rate of 5,9% (3/50) in the mesh group and 33,3% (33/100) in the control group. There was no statistically significant difference in the incidence of surgical site infection or other complications when prophylactic mesh group was compared to standard closure group. SSI rate in Swiss study was 60% and respectively only 17% in the Spanish study. This may reflect differences in the patient selection, therefore the safety profile of the prophylactic mesh in the emergency setting has not been adequately described. Neither of the studies included in meta-analysis were not randomized controlled trials. There were also many methodological differences including patient selection, used mesh, and mesh placement. Thus, the conclusion of the systematic review paper was that there are limited data to assess the effect or safety of the use of prophylactic mesh in the emergency laparotomy setting. Randomized control trials are required to address this important clinical question. EHS guideline group resulted the same conclusion in their recommendation report.

There are about 1650 patients are operated in Finland because of IH every year. According to the European study, the estimated cost for IH surgery is 6450 euros. The corresponding costs in Sweden were even higher reaching 9060 euros per treatment. Extrapolated to Finland, this means that operative treatment of IHs cause more than 10 million expenses to the Finnish health care sector in a year. Some of these costs may be avoidable by using the prophylactic mesh during the closure of midline emergency laparotomies in the patients with IH risk factors.

Being tested
Prophylactic self gripping mesh, Slowly absorbable continuous monofilament suture
Medical subject headings
Incisional Hernia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Prophylactic self gripping meshDevice

    Prophylactic self gripping mesh, Propgrip by Medtronic.

  • Slowly absorbable continuous monofilament sutureDevice

    Fascial closure by continuous slowly absorbable 4:1 suture

Study groups in NCT04311788
Study groupRoleWhat they receive
Intervention groupExperimentalProphylactic self gripping mesh (Program, Medtronic) will be placed in rectorectus space to prevent incisional hernia.
Receives: Device: Prophylactic self gripping mesh
Control groupActive comparatorAbdomen of the patients in the control group will be closed by using small stitch closure with suture to wound length of 4:1 and slowly absorbable monofilament suture.
Receives: Device: Slowly absorbable continuous monofilament suture

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of incisional hernia

    Incidence of incisional hernia, either symptomatic or asymptomatic detected clinically and/or radiologically

    Measured: 2 years

Secondary outcomes (10)
  1. Comprehensive Complication Index

    Comprehensive Complication Index

    Measured: 30 days

  2. Surgical site infection (SSI) rate

    Surgical site infection (SSI) rate defined by CDC classification of surgical site infection

    Measured: 30 days

  3. Fascial rupture

    Incidence of fascial rupture

    Measured: 30 days

  4. Incisional hernia

    Incisional hernia incidence during long-term follow-up

    Measured: 5 years

  5. Incisional hernia repair rate

    Incisional hernia repair rate during follow-up

    Measured: 5 years

  6. Re-operations

    Re-operations due to mesh- or hernia related indications

    Measured: 5 years

  7. Quality of life by RAND-36

    Quality of life defined by RAND-36

    Measured: 5 years

  8. Quality of life by Promis

    Quality of life defined by Promis questionnaire

    Measured: 5 years

  9. Quality of life by AAS

    Quality of life defined by AAS questionnaire

    Measured: 5 years

  10. Cost analysis

    All differences in costs between the groups will be analyzed

    Measured: 5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2020
  2. Study start27 Apr 2020
  3. Primary completion3 Feb 2025 (estimated)
  4. Study completionMar 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
109 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04311788
Sponsor's protocol ID
3/2020
Status last verified
Jan 2024
First submitted
7 Mar 2020
Last updated
1 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Makarainen E, Tolonen M, Sallinen V, Mentula P, Leppaniemi A, Ahonen M, Saarnio J, Pinta T, Lampela H, Malmi H, Lietzen E, Nikki M, Ohtonen P, Muysoms F, Rautio T. Prophylactic Retrorectus Mesh Versus Small-Stitch Closure After Emergency Midline Laparotomy: 2-Year Results of a Randomized Controlled Trial. J Abdom Wall Surg. 2025 Nov 27;4:15500. doi: 10.3389/jaws.2025.15500. eCollection 2025.

    PubMed 41394095
  • Makarainen E, Tolonen M, Sallinen V, Mentula P, Leppaniemi A, Ahonen-Siirtola M, Saarnio J, Ohtonen P, Muysoms F, Rautio T. Prophylactic retrorectus mesh versus no mesh in midline emergency laparotomy closure for prevention of incisional hernia (PREEMER): study protocol for a multicentre, double-blinded, randomized controlled trial. BJS Open. 2022 Jan 6;6(1):zrab142. doi: 10.1093/bjsopen/zrab142.

    PubMed 35143628

Questions about this trial

What is this clinical trial studying?

A study testing Prophylactic self gripping mesh and Slowly absorbable continuous monofilament suture in people with Incisional Hernia and Emergency Laparotomy, run by University of Oulu at 7 sites in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 18 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 1 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of incisional hernia (time frame: 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04311788, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in